Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Soft Robotics
|
July 7, 2022
Topology and Morphology Design of Spherically Reconfigurable Homogeneous Modular Soft Robots
Caitlin Freeman, Michael Maynard, Vishesh Vikas
Journal of Neurodevelopmental Disorders
|
June 9, 2019
In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?
Zahra Motahari, Sally Ann Moody, Thomas Michael Maynard, et al.
The Journal of Comparative Neurology
|
September 28, 2002
Retinoic acid signaling at sites of plasticity in the mature central nervous system
Gloria Thompson Haskell, Thomas Michael Maynard, Ron Andrew Shatzmiller, et al.
Antimicrobial Agents and Chemotherapy
|
March 28, 2018
Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model
Arnold Louie, Michael Maynard, Brandon Duncanson, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2021
Polymyxin B Pharmacodynamics in the Hollow-Fiber Infection Model: What You See May Not Be What You Get
Michael Maynard, G L Drusano, Michael Vicchiarelli, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model
G L Drusano, M N Neely, W M Yamada, et al.
Vaccine
|
December 18, 2013
Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response
Michael Maynard-Smith, Helen Ahern, Joanna McGlashan, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Orthopaedic Journal of Sports Medicine
|
July 12, 2021
Return to Sport After Bone-Patellar Tendon-Bone Autograft ACL Reconstruction in High School-Aged Athletes
Ryan C Rauck, John M Apostolakos, Benedict U Nwachukwu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Soft Robotics
|
July 7, 2022
Topology and Morphology Design of Spherically Reconfigurable Homogeneous Modular Soft Robots
Caitlin Freeman, Michael Maynard, Vishesh Vikas
Journal of Neurodevelopmental Disorders
|
June 9, 2019
In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?
Zahra Motahari, Sally Ann Moody, Thomas Michael Maynard, et al.
The Journal of Comparative Neurology
|
September 28, 2002
Retinoic acid signaling at sites of plasticity in the mature central nervous system
Gloria Thompson Haskell, Thomas Michael Maynard, Ron Andrew Shatzmiller, et al.
Antimicrobial Agents and Chemotherapy
|
March 28, 2018
Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model
Arnold Louie, Michael Maynard, Brandon Duncanson, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2021
Polymyxin B Pharmacodynamics in the Hollow-Fiber Infection Model: What You See May Not Be What You Get
Michael Maynard, G L Drusano, Michael Vicchiarelli, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model
G L Drusano, M N Neely, W M Yamada, et al.
Vaccine
|
December 18, 2013
Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response
Michael Maynard-Smith, Helen Ahern, Joanna McGlashan, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Orthopaedic Journal of Sports Medicine
|
July 12, 2021
Return to Sport After Bone-Patellar Tendon-Bone Autograft ACL Reconstruction in High School-Aged Athletes
Ryan C Rauck, John M Apostolakos, Benedict U Nwachukwu, et al.
Page
of 2